CIBC Private Wealth Group
APDNW

CIBC Private Wealth Group’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

CIBC Private Wealth Group’s Portfolio APDNW Stock Details APDNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,205
Closed -$5K – 988
2018
Q3 		$5K Hold
19,205
– – ﹤0.01% 961
2018
Q2 		$5K Hold
19,205
– – ﹤0.01% 1743
2018
Q1 		$5K Hold
19,205
– – ﹤0.01% 1681
2017
Q4 		$7K Hold
19,205
– – ﹤0.01% 1640
2017
Q3 		$13K Buy
+19,205
New +$9.17K ﹤0.01% 920

Other funds holding APDNW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

CIBC Private Wealth Group's APDNW Position: Q4 2018 in Review

CIBC Private Wealth Group sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q4 2018, closing a stake of 19,205 shares — an estimated $5K sold.

CIBC Private Wealth Group first reported a position in APDNW in Q3 2017 and held it in 5 quarters. The position peaked at $13K in Q3 2017. 6 funds tracked by Wall St. Rank hold APDNW as of Q4 2018.

  • CIBC Private Wealth Group reported no remaining Applied DNA Sciences Inc Warrant position as of Q4 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 19,205 Applied DNA Sciences Inc Warrant shares in Q4 2018, an estimated $5K.
  • CIBC Private Wealth Group first reported a position in Applied DNA Sciences Inc Warrant in Q3 2017 and held it in 5 quarters.
  • CIBC Private Wealth Group's Applied DNA Sciences Inc Warrant position peaked at $13K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q4 2018.

Based on CIBC Private Wealth Group's 13F filing for Q4 2018, filed 5 Feb 2019.